cdmo.directory
← Compare landing

Piramal Pharma Solutions vs Samsung Biologics

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryPiramal Pharma SolutionsSamsung Biologics
SummaryCDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.Leading CDMO offering end-to-end biologics development and manufacturing from cell line development through aseptic fill-finish, with capabilities in drug substance, drug product, ADC, and mRNA services.
Services
  • API Synthesis & Manufacturing
  • HPAPI Manufacturing (High-Potency)
  • Controlled Substance Manufacturing
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Bioconjugation Services
  • Peptide Manufacturing
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Oral Solid Dosage Manufacturing
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • CMC Regulatory Submission Support
  • Biologics Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Vaccine Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Process Development
  • Formulation Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Peptide
  • Vaccine
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • mRNA
  • Vaccine
Development capabilities
  • Analytical method development
  • Formulation development
  • Analytical method development
  • Formulation development
  • ICH stability testing
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Oral Solid Dose (OSD)
  • HPAPI
  • DEA licensed
  • Drug Substance (DS)
  • Drug Product (DP)
  • Liquid Vials
  • Lyophilized Vials
  • Prefilled Syringes (PFS)
  • Cartridges
  • Max bioreactor: Large commercial (≤10,000 L)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
  • Stainless Steel
Locations
  • Grangemouth, Grangemouth, Scotland, United Kingdom
  • Shanghai, Shanghai, China
  • Sourcing Office, Shanghai, China
  • Bio Campus I, South Korea
  • Bio Campus II, South Korea
  • Headquarters / Bio Campus I, Incheon, Yeonsu-gu, Republic of Korea
  • Bio Campus II, Incheon, Yeonsu-gu, Republic of Korea
  • ADC Plant, Incheon, Yeonsu-gu, Republic of Korea
  • Samsung Biologics America, United States
  • Samsung Biologics Japan Office, Japan
  • Headquarters
Certifications
  • MHRA · Identifier: GMP Certificate
  • GMP · Identifier: GMP
  • ISO · Identifier: ISO 9001, 14001, 45001
  • FAMI-QS · Identifier: FAMI-QS
  • ISO · Identifier: ISO 9001
  • ISO · Identifier: ISO 14001
  • ISO · Identifier: ISO 45001
Data not yet provided.

Find similar companies

Piramal Pharma Solutions alternatives · Samsung Biologics alternatives

Markdown mirror: /compare/piramalpharmasolutions/samsungbiologics.md